Anthony H Nguyen

Array ( [id] => 1365994 [patent_doc_number] => 06566127 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor' [patent_app_type] => B1 [patent_app_number] => 09/371772 [patent_app_country] => US [patent_app_date] => 1999-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 43 [patent_no_of_words] => 25925 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566127.pdf [firstpage_image] =>[orig_patent_app_number] => 09371772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1404691 [patent_doc_number] => 06538177 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'Compositions and methods for fumonisin detoxification' [patent_app_type] => B1 [patent_app_number] => 09/351150 [patent_app_country] => US [patent_app_date] => 1999-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 51143 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/538/06538177.pdf [firstpage_image] =>[orig_patent_app_number] => 09351150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4134343 [patent_doc_number] => 06034228 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Human signal transduction serine/threonine kinase' [patent_app_type] => 1 [patent_app_number] => 9/340993 [patent_app_country] => US [patent_app_date] => 1999-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24888 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/034/06034228.pdf [firstpage_image] =>[orig_patent_app_number] => 340993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1384846 [patent_doc_number] => 06548302 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-15 [patent_title] => 'Polymers for delivery of nucleic acids' [patent_app_type] => B1 [patent_app_number] => 09/336390 [patent_app_country] => US [patent_app_date] => 1999-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 22 [patent_no_of_words] => 30833 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/548/06548302.pdf [firstpage_image] =>[orig_patent_app_number] => 09336390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404644 [patent_doc_number] => 06171821 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'XIAP IRES and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/332319 [patent_app_country] => US [patent_app_date] => 1999-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 15125 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/171/06171821.pdf [firstpage_image] =>[orig_patent_app_number] => 332319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4093488 [patent_doc_number] => 06096539 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Protein activator of apoptosis' [patent_app_type] => 1 [patent_app_number] => 9/329418 [patent_app_country] => US [patent_app_date] => 1999-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 22205 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096539.pdf [firstpage_image] =>[orig_patent_app_number] => 329418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407454 [patent_doc_number] => 06172049 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'Phosphonic acid-based cationic lipids' [patent_app_type] => 1 [patent_app_number] => 9/326840 [patent_app_country] => US [patent_app_date] => 1999-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12394 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/172/06172049.pdf [firstpage_image] =>[orig_patent_app_number] => 326840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4352601 [patent_doc_number] => 06214986 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Antisense modulation of bcl-x expression' [patent_app_type] => 1 [patent_app_number] => 9/323743 [patent_app_country] => US [patent_app_date] => 1999-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22869 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214986.pdf [firstpage_image] =>[orig_patent_app_number] => 323743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4085394 [patent_doc_number] => 06132997 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Method for linear mRNA amplification' [patent_app_type] => 1 [patent_app_number] => 9/322692 [patent_app_country] => US [patent_app_date] => 1999-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8682 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/132/06132997.pdf [firstpage_image] =>[orig_patent_app_number] => 322692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1507140 [patent_doc_number] => 06440743 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Methods of using polynucleotide compositions' [patent_app_type] => B1 [patent_app_number] => 09/320640 [patent_app_country] => US [patent_app_date] => 1999-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20050 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440743.pdf [firstpage_image] =>[orig_patent_app_number] => 09320640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1453172 [patent_doc_number] => 06461815 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-08 [patent_title] => 'Antibacterial agents and methods of screening for the same' [patent_app_type] => B1 [patent_app_number] => 09/315674 [patent_app_country] => US [patent_app_date] => 1999-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 6734 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/461/06461815.pdf [firstpage_image] =>[orig_patent_app_number] => 09315674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4190009 [patent_doc_number] => 06043060 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-28 [patent_title] => 'Nucleotide analogues' [patent_app_type] => 1 [patent_app_number] => 9/308367 [patent_app_country] => US [patent_app_date] => 1999-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5223 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/043/06043060.pdf [firstpage_image] =>[orig_patent_app_number] => 308367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4167590 [patent_doc_number] => 06083482 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Conformationally locked nucleosides and oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 9/309742 [patent_app_country] => US [patent_app_date] => 1999-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5315 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083482.pdf [firstpage_image] =>[orig_patent_app_number] => 309742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4158343 [patent_doc_number] => 06107479 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Process for the preparation of an oligomeric compound' [patent_app_type] => 1 [patent_app_number] => 9/297709 [patent_app_country] => US [patent_app_date] => 1999-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6999 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107479.pdf [firstpage_image] =>[orig_patent_app_number] => 297709 [rel_patent_id] =>[rel_patent_doc_number] =>)